These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33098793)

  • 1. Provisional case definitions for COVID-19-associated neurological disease.
    Li HF; Hao HJ; Chen XJ
    Lancet Neurol; 2020 Nov; 19(11):890-891. PubMed ID: 33098793
    [No Abstract]   [Full Text] [Related]  

  • 2. The neurological impact of COVID-19.
    The Lancet Neurology
    Lancet Neurol; 2020 Jun; 19(6):471. PubMed ID: 32470408
    [No Abstract]   [Full Text] [Related]  

  • 3. Neurological complications of COVID-19: from bridesmaid to bride.
    Nath A; Smith B
    Arq Neuropsiquiatr; 2020 Sep; 78(8):459-460. PubMed ID: 32901698
    [No Abstract]   [Full Text] [Related]  

  • 4. The Coronavirus Disease 2019 Crisis as Catalyst for Telemedicine for Chronic Neurological Disorders.
    Bloem BR; Dorsey ER; Okun MS
    JAMA Neurol; 2020 Aug; 77(8):927-928. PubMed ID: 32329796
    [No Abstract]   [Full Text] [Related]  

  • 5. Health care for chronic neurological patients after COVID-19.
    Antonini A
    Lancet Neurol; 2020 Jul; 19(7):562-563. PubMed ID: 32464102
    [No Abstract]   [Full Text] [Related]  

  • 6. Rethinking Regional Neurologic Care in the Coronavirus Disease 2019 Era.
    George BP; Kelly AG
    JAMA Neurol; 2020 Sep; 77(9):1061-1062. PubMed ID: 32597937
    [No Abstract]   [Full Text] [Related]  

  • 7. NeuroCOVID: it's time to join forces globally.
    Helbok R; Chou SH; Beghi E; Mainali S; Frontera J; Robertson C; Fink E; Schober M; Moro E; McNett M; Bassetti CL; ;
    Lancet Neurol; 2020 Oct; 19(10):805-806. PubMed ID: 32949535
    [No Abstract]   [Full Text] [Related]  

  • 8. Tackling the Burden of Neurological Diseases in Canada with Virtual Care During the COVID-19 Pandemic and Beyond.
    Appireddy R; Jalini S; Shukla G; Boissé Lomax L
    Can J Neurol Sci; 2020 Sep; 47(5):594-597. PubMed ID: 32394872
    [No Abstract]   [Full Text] [Related]  

  • 9. European Society of Minimally Invasive Neurological Therapy (ESMINT) recommendations for optimal interventional neurovascular management in the COVID-19 era.
    Aggour M; White P; Kulcsar Z; Fiehler J; Brouwer P
    J Neurointerv Surg; 2020 Jun; 12(6):542-544. PubMed ID: 32303584
    [No Abstract]   [Full Text] [Related]  

  • 10. Demographic characteristics and neurological comorbidity of patients with COVID-19.
    Acar T; Acar BA; Aras YG; Doğan T; Boncuk S; Eryılmaz HA; Can N; Can Y
    Rev Assoc Med Bras (1992); 2020; 66Suppl 2(Suppl 2):82-85. PubMed ID: 32965362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [COVID-19: A neurological point-of-view].
    Simon OJ; Timmermann L
    Dtsch Med Wochenschr; 2020 Jul; 145(15):1074-1079. PubMed ID: 32731282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System.
    De Felice FG; Tovar-Moll F; Moll J; Munoz DP; Ferreira ST
    Trends Neurosci; 2020 Jun; 43(6):355-357. PubMed ID: 32359765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological manifestations in coronavirus disease 2019.
    Corona T; Rodríguez-Violante M; Delgado-García G
    Gac Med Mex; 2020; 156(4):317-320. PubMed ID: 32831319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rising evidence for neurological involvement in COVID-19 pandemic.
    Calcagno N; Colombo E; Maranzano A; Pasquini J; Keller Sarmiento IJ; Trogu F; Silani V
    Neurol Sci; 2020 Jun; 41(6):1339-1341. PubMed ID: 32394275
    [No Abstract]   [Full Text] [Related]  

  • 15. Sars-Cov-2: Underestimated damage to nervous system.
    Zhou L; Zhang M; Wang J; Gao J
    Travel Med Infect Dis; 2020; 36():101642. PubMed ID: 32220634
    [No Abstract]   [Full Text] [Related]  

  • 16. [Neurological aspects of the COVID-19 pandemic caused by the SARS-CoV-2 coronavirus].
    Bereczki D; Stang R; Böjti P; Kovács T
    Ideggyogy Sz; 2020 May; 73(05-06):171-175. PubMed ID: 32579306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dementia in the COVID-19 Period.
    Korczyn AD
    J Alzheimers Dis; 2020; 75(4):1071-1072. PubMed ID: 32538858
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuropathology of COVID-19: where are the neuropathologists?
    Glatzel M
    Brain Pathol; 2020 Jul; 30(4):729. PubMed ID: 32592310
    [No Abstract]   [Full Text] [Related]  

  • 19. New clinical needs and strategies for care in children with neurodisability during COVID-19.
    Fazzi E; Galli J
    Dev Med Child Neurol; 2020 Jul; 62(7):879-880. PubMed ID: 32358977
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuro-ophthalmology in the Era of COVID-19: Future Implications of a Public Health Crisis.
    Grossman SN; Calix R; Tow S; Odel JG; Sun LD; Balcer LJ; Galetta SL; Rucker JC
    Ophthalmology; 2020 Sep; 127(9):e72-e74. PubMed ID: 32387481
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.